Federal Court Voids Changes to Patent Office Rules on Continuation & Claims Practice


On April 1, 2008, the United States District Court for the Eastern District of Virginia declared void the “Changes to Practice for Continued Examination Filings, Patent Applications Containing Patentably Indistinct Claims, and Examination of Claims in Patent Applications,” 72 Fed. Reg. 46716-46843 (August 21, 2007) (“Final Rules”), proposed by the United States Patent and Trademark Office (“USPTO”). Judge James C. Cacheris granted Summary Judgment in favor of plaintiffs GlaxoSmithKline and Triantafyllos Tafas and permanently enjoined the USPTO from implementing the Final Rules that were to have taken effect on November 1, 2007.[1]

The Final Rules imposed limits on the number of continuing applications, requests for continued examination (“RCEs”), and continuation-in-part applications and the number of claims permissible as of right in a given patent application family and, in certain circumstances, added the requirement for an onerous examination support document (“ESD”).

Citing precedent from the United States Supreme Court and the United States Court of Appeals for the Federal Circuit, the court held that 35 U.S.C. § 2(b)(2) does not permit the USPTO to issue substantive rules or render substantive decisions interpreting the Patent Act. The court also based

its decision on Congress’s failure to confer upon the USPTO substantive rulemaking authority as part of Patent Reform legislation proposed since 2005.

LOADING PDF: If there are any problems, click here to download the file.

Written by:


Morrison & Foerster LLP on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.